Almanack Investment Partners’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-6,361
| Closed | -$755K | – | 187 |
|
2024
Q2 | $755K | Buy |
+6,361
| New | +$755K | 0.13% | 91 |
|
2023
Q2 | – | Sell |
-1,480
| Closed | -$227K | – | 173 |
|
2023
Q1 | $227K | Sell |
1,480
-3,650
| -71% | -$561K | 0.04% | 151 |
|
2022
Q4 | $921K | Sell |
5,130
-9,448
| -65% | -$1.7M | 0.2% | 56 |
|
2022
Q3 | $1.72M | Buy |
+14,578
| New | +$1.72M | 0.34% | 41 |
|
2022
Q2 | – | Sell |
-2,379
| Closed | -$410K | – | 493 |
|
2022
Q1 | $410K | Buy |
2,379
+737
| +45% | +$127K | 0.04% | 296 |
|
2021
Q4 | $417K | Buy |
1,642
+873
| +114% | +$222K | 0.03% | 294 |
|
2021
Q3 | $296K | Buy |
+769
| New | +$296K | 0.03% | 377 |
|